Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
34.9M
-
Shares change
-
-255K
-
Total reported value, excl. options
-
$1.34B
-
Value change
-
-$5.48M
-
Put/Call ratio
-
4.61
-
Number of buys
-
52
-
Number of sells
-
-48
-
Price
-
$38.42
Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q2 2021
124 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q2 2021.
Replimune Group, Inc. - COMMON STOCK (REPL) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.9M shares
of 78.4M outstanding shares and own 44.49% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (5.07M shares), Omega Fund Management, LLC (5.01M shares), Redmile Group, LLC (4.19M shares), BlackRock Inc. (1.98M shares), STATE STREET CORP (1.68M shares), Ensign Peak Advisors, Inc (1.46M shares), VANGUARD GROUP INC (1.43M shares), FMR LLC (1.05M shares), LOOMIS SAYLES & CO L P (993K shares), and BVF INC/IL (919K shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.